One of the most widely-used asthma and breathing treatments for over 20 years is being taken off the shelves in 2024, potentially leaving patients, healthcare providers and insurers scrambling.

After Flovent, one of the most popular inhalers for treating childhood asthma, was discontinued this past January, some parents are reporting challenges in obtaining the generic versions of the ...

Some asthma patients may start out the new year scrambling for their go-to inhaler – at least that's the concern as Flovent, a popular drug, leaves store shelves starting in January. Earlier this year ...

A mid-afternoon inhaler dose might be best for controlling asthma symptoms Taking a single dose around 4 p.m. worked better than a morning dose or doses taken at morning and evening That timing ...

Please provide your email address to receive an email when new articles are posted on . For mild to moderate asthma, many providers reported prescribing a 110 µg/actuation fluticasone metered dose ...

In this April 4, 2017 photo, Javier Sua demonstrates how he uses an inhaler at his home in Fresno, Calif. He uses it to combat asthma, made worse by air pollution in the San Joaquin Valley. A new ...

Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim. Following ...

Dr. Miguel Divo, a lung specialist at Brigham and Women’s Hospital, sits in an exam room, across from one of his patients with asthma. Joel Rubinstein, a retired psychiatrist, is about to get a ...

GSK has secured approval in China for Trelegy Ellipta as a maintenance treatment for adults with asthma, adding to its existing indication in COPD and making it the only single inhaler triple therapy ...